Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v4-FR
Language French French
Date Updated 2024-01-19 2023-12-01
Drug Identification Number 02471094 02471094
Brand name APO-ARIPIPRAZOLE APO-ARIPIPRAZOLE
Common or Proper name ARIPIPRAZOLE ARIPIPRAZOLE
Company Name APOTEX INC APOTEX INC
Ingredients ARIPIPRAZOLE ARIPIPRAZOLE
Strength(s) 5MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30 BTL 30 BTL
ATC code N05AX N05AX
ATC description ANTIPSYCHOTICS ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-11-06 2023-11-06
Estimated end date 2024-01-19 2024-02-29
Actual end date 2024-01-18
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments